Market Overview:
The global liver cirrhosis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of liver cirrhosis, rising awareness about various types of liver cirrhosis, and growing demand for better treatment options for patients with liver cirrhosis. Based on type, the global liver cirrhosis market is segmented into alcoholic cirrhosis, atrophic cirRHOSIS, biliary CirRHOSIS, cardiac CirRHOSIS cryptogenic CirRHOSIS. Alcoholic CirRHOSIS is the most common type of Liver CirRhosIs and accounts for more than half of all cases in developed countries. Based on application, the global Liver CirRhosIs market is segmented into hospitals and specialty clinics. Hospitals are expected to account for a larger share of the market than specialty clinics during the forecast period owing to increasing number of patients with advanced stages of Liver CirRhosIs requiring hospitalization for treatment. Geographically, North America dominates the global Liver Cyrhossis Market followed by Europe and Asia Pacific region respectively due To high prevalence Of alcohol-related Liver Cyrhossis In these regions And Increasing geriatric population susceptible To various types Of cyrhossis including hepatic cyrhossis .
Product Definition:
Liver cirrhosis is a condition in which the liver becomes scarred and its function is impaired. This can lead to numerous complications, including fluid accumulation in the abdomen (ascites), bleeding from varices around the stomach, infection, and coma. Liver cirrhosis is a serious condition that can be fatal.
Alcoholic Cirrhosis:
Alcoholic cirrhosis is a chronic liver disease caused by excessive alcohol consumption. It is characterized by portal hypertension, bile duct proliferation, and fibrosis of the liver. The condition may progress to become life-threatening within months or years of the last drink (onset).
The major factor contributing to the development of alcoholic cirrhosis includes heavy alcohol consumption.
Atrophic Cirrhosis:
Atrophic cirrhosis is a condition where there is loss of connective tissue in the body, which results in shrinkage of lumps called liver tumors. The shrinking of these tumors reduces the size and function ability of the liver. Atrophic cirrhosis can be diagnosed through ultrasound imaging tests or through biopsy techniques that are done to remove small samples from different parts of the liver for microscopic analysis under a microscope.
Application Insights:
Based on application, the liver cirrhosis market is segmented into hospitals and specialty clinics. Hospitals held the largest share of over 70.0% in 2017 owing to factors such as high prevalence of alcoholic liver disease and biliary disorders that require long-term care & treatment.
Specialty clinics are anticipated to witness lucrative growth during the forecast period due to increasing awareness about various treatment options, availability of advanced treatments, growing preference for outpatient surgeries, rising income levels among patients as well as increasing government funding for research on chronic diseases such as cancer & diabetes. For instance, according to a study published by NCBI in 2018; it was estimated that around USD 25 billion were spent by governments worldwide on cancer care programs in 2014 while around USD 22 billion were spent by governments worldwide on diabetes program in 2014 respectively.
Regional Analysis:
Europe dominated the global liver cirrhosis market in 2017. The presence of well-established healthcare facilities and highly developed primary, secondary, and tertiary care hospitals is one of the major factors responsible for dominance. In addition, high prevalence of chronic diseases such as diabetes and alcohol consumption are also contributing towards dominance.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to increasing geriatric population base coupled with rising lifestyle disorders such as cardiac arrest & obesity that result into increased risk for developing ALD.
Growth Factors:
- Increasing prevalence of chronic liver diseases such as hepatitis C and cirrhosis due to unhealthy lifestyle habits and alcohol consumption.
- Growing awareness about the early diagnosis and treatment of liver cirrhosis through public health campaigns and initiatives by government and non-profit organizations.
- Rising demand for novel therapeutics for the treatment of liver cirrhosis, such as stem cell therapy, regenerative medicine, etc.
- Technological advancements in the field of diagnostics that can help in early detection of liver cirrhosis at an earlier stage.
Scope Of The Report
Report Attributes
Report Details
Report Title
Liver Cirrhosis Market Research Report
By Type
Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis
By Application
Hospitals, Specialty Clinics
By Companies
F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Merck, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Liver Cirrhosis Market Report Segments:
The global Liver Cirrhosis market is segmented on the basis of:
Types
Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F Hoffman La-Roche
- GlaxoSmithKline
- Gilead Sciences
- Johnson & Johnson
- Merck
- Bristol-Myers Squibb
- Conatus Pharmaceuticals
- Gwo Xi Stem Cell Applied Technology
- Instituto Grifols
- Intercept Pharmaceuticals
Highlights of The Liver Cirrhosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alcoholic Cirrhosis
- Atrophic Cirrhosis
- Biliary Cirrhosis
- Cardiac Cirrhosis
- Cryptogenic Cirrhosis
- By Application:
- Hospitals
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liver Cirrhosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liver cirrhosis is a serious condition in which the liver becomes damaged and can no longer function properly. The damage may be caused by alcohol abuse, hepatitis C, or other factors. Symptoms of liver cirrhosis include fatigue, jaundice (yellowing of the skin and eyes), nausea and vomiting, abdominal pain, dark urine, clay-colored stools (faeces), fever and weight loss. If left untreated, liver cirrhosis can lead to death.
Some of the major companies in the liver cirrhosis market are F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Merck, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals.
The liver cirrhosis market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liver Cirrhosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liver Cirrhosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liver Cirrhosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liver Cirrhosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liver Cirrhosis Market Size & Forecast, 2018-2028
4.5.1 Liver Cirrhosis Market Size and Y-o-Y Growth
4.5.2 Liver Cirrhosis Market Absolute $ Opportunity
Chapter 5 Global Liver Cirrhosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Liver Cirrhosis Market Size Forecast by Type
5.2.1 Alcoholic Cirrhosis
5.2.2 Atrophic Cirrhosis
5.2.3 Biliary Cirrhosis
5.2.4 Cardiac Cirrhosis
5.2.5 Cryptogenic Cirrhosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Liver Cirrhosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Liver Cirrhosis Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liver Cirrhosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liver Cirrhosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liver Cirrhosis Analysis and Forecast
9.1 Introduction
9.2 North America Liver Cirrhosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liver Cirrhosis Market Size Forecast by Type
9.6.1 Alcoholic Cirrhosis
9.6.2 Atrophic Cirrhosis
9.6.3 Biliary Cirrhosis
9.6.4 Cardiac Cirrhosis
9.6.5 Cryptogenic Cirrhosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Liver Cirrhosis Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Liver Cirrhosis Analysis and Forecast
10.1 Introduction
10.2 Europe Liver Cirrhosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liver Cirrhosis Market Size Forecast by Type
10.6.1 Alcoholic Cirrhosis
10.6.2 Atrophic Cirrhosis
10.6.3 Biliary Cirrhosis
10.6.4 Cardiac Cirrhosis
10.6.5 Cryptogenic Cirrhosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Liver Cirrhosis Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Liver Cirrhosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liver Cirrhosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liver Cirrhosis Market Size Forecast by Type
11.6.1 Alcoholic Cirrhosis
11.6.2 Atrophic Cirrhosis
11.6.3 Biliary Cirrhosis
11.6.4 Cardiac Cirrhosis
11.6.5 Cryptogenic Cirrhosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Liver Cirrhosis Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Liver Cirrhosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Liver Cirrhosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liver Cirrhosis Market Size Forecast by Type
12.6.1 Alcoholic Cirrhosis
12.6.2 Atrophic Cirrhosis
12.6.3 Biliary Cirrhosis
12.6.4 Cardiac Cirrhosis
12.6.5 Cryptogenic Cirrhosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Liver Cirrhosis Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Liver Cirrhosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liver Cirrhosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liver Cirrhosis Market Size Forecast by Type
13.6.1 Alcoholic Cirrhosis
13.6.2 Atrophic Cirrhosis
13.6.3 Biliary Cirrhosis
13.6.4 Cardiac Cirrhosis
13.6.5 Cryptogenic Cirrhosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Liver Cirrhosis Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liver Cirrhosis Market: Competitive Dashboard
14.2 Global Liver Cirrhosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F Hoffman La-Roche
14.3.2 GlaxoSmithKline
14.3.3 Gilead Sciences
14.3.4 Johnson & Johnson
14.3.5 Merck
14.3.6 Bristol-Myers Squibb
14.3.7 Conatus Pharmaceuticals
14.3.8 Gwo Xi Stem Cell Applied Technology
14.3.9 Instituto Grifols
14.3.10 Intercept Pharmaceuticals
